Recruiting

Galactic Cap

Sponsor:

Indiana University

Code:

NCT07947186

Conditions

Male Contraception

Contraceptive Device

Pregnancy Prevention

Prevention of Semen Exposure During Intercourse

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Galactic Cap

Study Details

Brief summary:

This is a Phase 1 feasibility study evaluating the safety, barrier efficacy, and user acceptability of a novel male contraceptive device, the Galactic Cap (GC), an adhesive, polyurethane-based barrier designed to cover the glans penis. Unlike traditional condoms, the device adheres directly to the penile surface to improve fit, reduce slippage, and enhance sensation through increased skin-to-skin contact and improved heat transfer. The study will enroll 40 monogamous heterosexual couples in which the male partner has undergone vasectomy, allowing assessment of device performance independent of pregnancy risk. Participants will use the device during four separate acts of vaginal intercourse over approximately one month, with data collected via genital examinations, participant diaries, post-use surveys, and pre- and post-coital vaginal swabs analyzed for prostate-specific antigen (PSA) to assess semen leakage. The primary objective is to evaluate safety, with secondary assessment of barrier effectiveness and exploratory evaluation of device performance and user satisfaction compared to traditional condoms.

Conditions

Male Contraception

Contraceptive Device

Pregnancy Prevention

Prevention of Semen Exposure During Intercourse

Study ID

NCT07947186

Start date

Oct 19, 2026

Status verified date

Nov, 2026

Completion date

Apr 19, 2027

Anticipated

Primary completion date

Apr 19, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:• Heterosexual couples in monogamous stable relationships (>6 months);

  • Both male and female participants are required to have >18 years old prior to entering the study;
  • Eligible men are those with a prior vasectomy and documented azoospermia on semen analysis prior to the baseline visit;
  • Patients must provide a signed and dated informed consent form, indicating their understanding and agreement to participate;
  • Patients must be willing to comply with all study procedures and be available for the duration of the study period;
  • Both male and female participants are required to have prior experience using a male condom during intercourse;
  • All participants (both male and female) must be in good general health based on their medical history and physical examination. At study entry, male participants must have no open penile lesions or lacerations as confirmed by genital exam, and female participants must have no vaginal lesions or lacerations as confirmed by vaginal exam. Participants with significant genital findings at baseline will not be included in this study.

Exclusion Criteria:

  • Participants will be excluded if they do not meet any of the inclusion criteria. Exclusion criteria comprise:

  • Couples who are not heterosexual or monogamous;
  • Relationships lasting less than six months;
  • Individuals under 18 years of age;
  • Male participants who have not undergone a prior vasectomy or who do not have a semen analysis confirming azoospermia before the baseline visit;
  • Inability or unwillingness to provide signed and dated informed consent;
  • Inability to comply with all study procedures;
  • Unavailability for the full duration of the study;
  • Either partner lacking prior experience with male condom use during intercourse;
  • Presence of penile or vaginal lesions or lacerations in either partner, detected during medical physical examination;

Study Design

Enrollment

80 participants

Anticipated

Intervention Model

Single group

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Galactic cap

Increase use of male contraception; Preventing transmission of bodily fluids

Interventions

Galactic Cap

Use galactic cap four times per week for two weeks

Primary outcome measure

  • Device Safety [ Time Frame: Day 1 to Day 30 ]

Central Contacts and Locations

Locations

Indiana University Men's Health Clinic Indiana University Health North Hospital

Recruiting

Carmel, Indiana, United States, 46032

Contacts

Helen Bernie, DO, MPH

317-688-5500hbernie@iu.edu

Indiana University Men's Health Clinic Indiana University Health North Hospital

Recruiting

Indianapolis, Indiana, United States, 46202

Contacts

More Information

Sponsor

Indiana University

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Indiana University on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.